Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology

Anemia, a frequent complication of cancer and its treatments, produces unwanted symptoms and significantly impairs metabolic and physiologic functions, as well as patients' activity, quality of life and even life expectancy.